Policy advocacy at the federal, state or local level can be an effective way to impact the "problem" of preeclampsia in the U.S. Public awareness, research funding levels, drug development and many more issues all vie for our attention, and for the attention of the leaders and influencers who can do something about it. Please help us set our advocacy agenda by taking a brief survey by Feb. 15. The survey asks you to weigh in on what you think our advocacy priorities should be, how you can get involved, types of actions you can take (from e-mailing to meeting with elected officials and their staff), and your preferred methods of communication. Your answers are very important to us and will take less than 10 minutes to provide.
Visit our advocacy page to learn more about how you can let your elected officials hear your voice and what we're doing in Washington, DC, and elsewhere. For instance, USAID recently published an Update to their Five-Year Strategy on Maternal Health, with extensive plans to decrease maternal mortality due to preeclampsia and eclampsia. While our respective organizations may disagree on strategies, we are very much in agreement that a woman's "ability to recognize the signs and symptoms of an illness, its perceived severity, and maternal health care-seeking behaviors during pregnancy and the postnatal period are associated with maternal-newborn mortality and morbidity outcomes."
May is Preeclampsia Awareness Month and we are seeking a Congressional Proclamation to support our national awareness efforts. We'll need your support to succeed, so stay tuned for ways you can help.